Collectively, the findings in this study suggest that BCL9, by enhancement of canonical Wnt signaling and initiating an EMT program, serves as an important molecular driver in invasive transition of human DCIS. The gene discussed is BCL9; the disease is ductal breast carcinoma in situ.